Safety and efficacy of remimazolam tosilate for general anaesthesia in paediatric patients undergoing elective surgery: a multicentre, randomised, single‐blind, controlled trial
Anaesthesia · 2025-03 · 80 (3) · 259-268
DOI: 10.1111/anae.16475 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anaesthesia, online erschienen am 22.11.2024. Verfasst von Yu-Bo Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University…. Hauptthemen laut MEDLINE: Anesthesia, General, Elective Surgical Procedures, Benzodiazepines, Hypnotics and Sedatives. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Major Science and Technology Projects of Wenzhou, Zhejiang, China, Social Development Science and Technology Project of Taizhou City of China, Wenzhou Science and Technology Bureau.
Abstract (Originalsprache)
Introduction
Remimazolam is an ultra‐short‐acting benzodiazepine sedative drug. This study aimed to compare the efficacy and safety of remimazolam with propofol for induction and maintenance of general anaesthesia in children undergoing elective surgery.
Methods
Children (aged 3–6 y, ASA physical status 1 or 2, BMI 14–25 kg.m ‐2 ) undergoing elective surgery under general anaesthesia with tracheal intubation were eligible for inclusion. Children were allocated randomly using a web‐based system to receive either remimazolam or propofol in a 3:1 ratio. After receiving fentanyl 3 μg.kg ‐1 , children received their allocated drug for both induction and maintenance of general anaesthesia. Induction doses were remimazolam 0.3 mg.kg ‐1 or propofol 2.5 mg.kg ‐1 , with a second dose given should they not achieve loss of consciousness. After neuromuscular blockade and tracheal intubation, maintenance anaesthesia was achieved with an infusion either remimazolam 1–3 mg.kg ‐1 .h ‐1 or propofol 4–12 mg.kg ‐1 .h ‐1 , alongside a remifentanil infusion (0.1–0.5 μg.kg ‐1 .min ‐1 ) titrated to surgical stimulus and haemodynamic parameters. Primary outcomes were the incidence of successful induction and maintenance of anaesthesia. Secondary outcomes included: time to loss of consciousness, awakening and tracheal extubation; incidence of emergence delirium and moderate or severe pain in post‐anaesthesia care unit; incidence of negative behaviour change after surgery at postoperative day 3; and incidence of adverse events.
Results
A total of 187 children were analysed (140 allocated to remimazolam and 47 to propofol). All children achieved successful induction of anaesthesia. Successful maintenance of anaesthesia was achieved in 139 (99%) children who received remimazolam compared with 46 (98%) who received propofol (rate difference 1.4%, 95%CI ‐2.9–5.8%, p = 0.441). Adverse events occurred in 27 (19%) children who received remimazolam and 23 (49%) who received propofol.
Discussion
Remimazolam was well tolerated for the induction and maintenance of general anaesthesia in pre‐school‐age children and was non‐inferior to propofol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Key Laboratory of Paediatric Anaesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Anaesthesiology and Pain Management, University of Texas Southwestern Medical Centre, Dallas, TX, USA.
- Outcome Research Consortium, Cleveland, OH, USA.
- Department of Anaesthesiology, Children's Hospital of Chongqing Medical University, Chongqing, China.
- National Clinical Research Centre for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
ORCID-Profile: Yu-Bo Fang
Förderung
- Major Science and Technology Projects of Wenzhou, Zhejiang, China
- Social Development Science and Technology Project of Taizhou City of China
- Wenzhou Science and Technology Bureau
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Fang, Y. B., Zhong, J. W., Szmuk, P., Lyu, Y. L., Xu, Y., Qu, S., Du, Z., Shangguan, W., & Liu, H. C. (2025). Safety and efficacy of remimazolam tosilate for general anaesthesia in paediatric patients undergoing elective surgery: a multicentre, randomised, single‐blind, controlled trial. Anaesthesia, 80(3), 259-268. https://doi.org/10.1111/anae.16475
Vancouver
Fang YB, Zhong JW, Szmuk P, Lyu YL, Xu Y, Qu S, et al. Safety and efficacy of remimazolam tosilate for general anaesthesia in paediatric patients undergoing elective surgery: a multicentre, randomised, single‐blind, controlled trial. Anaesthesia. 2025;80(3):259-268. doi:10.1111/anae.16475
BibTeX
@article{Fang2025,
author = {Fang, Yu-Bo and Zhong, John Wei and Szmuk, Peter and Lyu, Yun-Long and Xu, Ying and Qu, Shuangquan and Du, Zhen and Shangguan, Wangning and Liu, Hua-Cheng},
title = {Safety and efficacy of remimazolam tosilate for general anaesthesia in paediatric patients undergoing elective surgery: a multicentre, randomised, single‐blind, controlled trial},
journal = {Anaesthesia},
year = {2025},
volume = {80},
number = {3},
pages = {259--268},
doi = {10.1111/anae.16475}
}
EUVIMED